In clinical terms, breast augmentation is referred to as augmentation mammoplasty. Breast implants can be either round shaped or teardrop/anatomical shaped. Round breast implants are the most commonly used breast implants and are highly preferred among women during breast augmentation procedures. Teardrop breast implants, also known as contoured implants, are designed to maintain their shape with a sloped contoured that fills out more at the bottom than at the top giving the natural shape of the breasts.
Asia Pacific breast implants market is estimated to account for US$ 329.5 Mn in terms of value by the end of 2027.
Asia Pacific Breast Implants Market: Drivers
Increasing focus on enhancing aesthetic appeal among women is expected to boost growth of Asia Pacific breast implants market over the forecast period. Several studies have demonstrated that breast implants can help boost self-esteem, body image, and sexual satisfaction. Majority of women are conscious about physical appearance of their breasts, which may also lead to high demand for breast augmentation.
Asia Pacific Breast Implants Market: Opportunities
R&D in breast implants is expected to offer lucrative growth opportunities for players in the market. For instance, in May 2019, researchers from Washington University (U.S.) reported development of a novel approach to evaluate the mechanical properties of breast implants.
Asia Pacific Breast Implants Market: Restraints
Increased risk of developing serious complications is expected to hinder growth of the market. Silicon implants are prone to breakdown or migration to another part of the body. Other complications include ruptures, leaks, and medical complications such as fibromyalgia or a thyroid problem.
The Silicone Breast Implant segment in Asia Pacific breast implants market was valued at US$ 167.3 Mn in 2019 and is expected to reach US$ 297.0 Mn by 2027 at a CAGR of 7.4% during the forecast period. The growth of the segment is attributed to increasing prevalence of breast cancer over the forecast period.
The Cosmetic Surgery segment held dominant position in Asia Pacific breast implants market in 2019, accounting for 75.9% share in terms of value during the forecast period. Major driver attributing to the growth of the segment is increasing number of breast augumnetation procedures.
Older women or those who have had multiple pregnancies prefer breast lift during breast augmentation to minimize recovery time and to reduce scarring.
Several plastic surgery centers are offering 3D images of breast implants to enhance customer convenience.
Asia Pacific Breast Implants Market: Competitive Landscape
Major players operating in Asia Pacific breast implants market include, Allergan, Plc (Actavis Plc), Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.), GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG), Establishment Labs S.A., CollPlant Holdings Ltd., HansBiomed Co., Ltd., Cereplas, and PS Technology Development Limited.
Asia Pacific Breast Implants Market: Key Developments
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in November 2019, Sientra, Inc., a medical aesthetics company, acquired FDA-approved silicone breast implant manufacturing operation from Lubrizol Life Science.
Players in the market are also focused on developing new products to expand their product portfolio. For instance, in August 2019, CollPlant Holdings Ltd., a regenerative medicine company, announced that it is developing 3D bio-printed implants for regeneration of breast tissues and has successfully produced first prototypes.
Scope of the report